Open Access

Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease

  • Authors:
    • Ang Chen
    • Jianlin Wen
    • Chuanghong Lu
    • Beiyou Lin
    • Shenglin Xian
    • Feng Huang
    • Yunjiao Wu
    • Zhiyu Zeng
  • View Affiliations

  • Published online on: December 6, 2019     https://doi.org/10.3892/ijmm.2019.4420
  • Pages: 429-440
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Autoimmunity is involved in the valvular damage caused by rheumatic heart disease (RHD). Increased evidence has linked microRNAs (miRNAs/miRs) to autoimmune disease. Signal transducer and activator of transcription 3 (STAT3) and sphingosine‑1‑phosphate receptor 1 (S1PR1) and suppressor of cytokine signaling 1 (SOCS1) have been widely studied for their roles in autoimmunity and inflammation. Thus, the current study aims to investigate the role played by miR‑155‑5p in RHD‑induced valvular damage via the S1PR1, SOCS1/STAT3 and interleukin (IL)‑6/STAT3 signaling pathways. An RHD rat model was induced by inactivated Group A streptococci and complete Freund's adjuvant. A recombinant adeno‑associated virus (AAV‑miR155‑inhibitor) was used to inhibit the expression of miR‑155‑5p in the heart. Inflammation and fibrosis were assessed by hematoxylin and eosin staining and Sirius red staining. The expression of miR‑155‑5p in valvular tissues and serum exosomes was detected by reverse transcription‑quantitative PCR. S1PR1, SOCS1, STAT3, phosphorylated STAT3, IL‑6 and IL‑17 protein expression was detected by western blotting and immunohistochemistry. The relationships between miR‑155‑5p and S1PR1 and SOCS1 were detected by dual luciferase assays. Cytokine concentrations were measured by ELISA. The expression of miR‑155‑5p in valve tissues and serum exosomes was increased along with decreased S1PR1 and activated SOCS1/STAT3 signaling in the RHD model. The expression of IL‑6 and IL‑17 was increased in the valves and the serum. Dual luciferase assays showed that miR‑155‑5p directly targeted S1PR1 and SOCS1. Inhibition of valvular miR‑155‑5p through AAV pretreatment increased S1PR1 expression and inhibited activation of the SOCS1/STAT3 signal pathway as a result of attenuated valvular inflammation and fibrosis as well as a decrease in IL‑6 and IL‑17 in the valves and serum. These results suggest that inhibition of miR‑155‑5p can reduce RHD‑induced valvular damage via the S1PR1, SOCS1/STAT3 and IL‑6/STAT3 signaling pathways.
View Figures
View References

Related Articles

Journal Cover

February 2020
Volume 45 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Chen, A., Wen, J., Lu, C., Lin, B., Xian, S., Huang, F. ... Zeng, Z. (2020). Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease . International Journal of Molecular Medicine, 45, 429-440. https://doi.org/10.3892/ijmm.2019.4420
MLA
Chen, A., Wen, J., Lu, C., Lin, B., Xian, S., Huang, F., Wu, Y., Zeng, Z."Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease ". International Journal of Molecular Medicine 45.2 (2020): 429-440.
Chicago
Chen, A., Wen, J., Lu, C., Lin, B., Xian, S., Huang, F., Wu, Y., Zeng, Z."Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease ". International Journal of Molecular Medicine 45, no. 2 (2020): 429-440. https://doi.org/10.3892/ijmm.2019.4420